Avenue Therapeutics, Inc.
ATXI
$0.773
-$0.1725-18.24%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -43.30% | 11.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.80% | -23.85% | |||
| Operating Income | -11.80% | 23.85% | |||
| Income Before Tax | -14.29% | 37.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.29% | 37.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 22.22% | 0.00% | |||
| Net Income | -14.26% | 37.97% | |||
| EBIT | -11.80% | 23.85% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 70.10% | 58.26% | |||
| Normalized Basic EPS | 20.20% | 68.84% | |||
| EPS Diluted | 70.10% | 58.26% | |||
| Normalized Diluted EPS | 20.20% | 68.84% | |||
| Average Basic Shares Outstanding | 43.16% | 98.90% | |||
| Average Diluted Shares Outstanding | 43.16% | 98.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
